# Cardioprotective effects of vaccination in hospitalized patients with COVID-19

## TL;DR

This study finds that being vaccinated against COVID-19 may protect the heart in hospitalized patients.

## Contribution

The study shows for the first time that vaccination reduces heart-related risks in hospitalized COVID-19 patients.

## Key findings

- Vaccinated patients had a 67% lower risk of acute cardiac events compared to non-vaccinated patients.
- Vaccinated patients had significantly lower troponin T levels, indicating less heart damage.
- Type 2 diabetes and existing heart disease increased the risk of acute cardiac events.

## Abstract

COVID-19 vaccination has been shown to prevent and reduce the severity of COVID-19 disease. The aim of this study was to explore the cardioprotective effect of COVID-19 vaccination in hospitalized COVID-19 patients. In this retrospective, single-center cohort study, we included hospitalized COVID-19 patients with confirmed vaccination status from July 2021 to February 2022. We assessed outcomes such as acute cardiac events and cardiac biomarker levels through clinical and laboratory data. Our analysis covered 167 patients (69% male, mean age 58 years, 42% being fully vaccinated). After adjustment for confounders, vaccinated hospitalized COVID-19 patients displayed a reduced relative risk for acute cardiac events (RR: 0.33, 95% CI [0.07; 0.75]) and showed diminished troponin T levels (Cohen’s d: − 0.52, 95% CI [− 1.01; − 0.14]), compared to their non-vaccinated peers. Type 2 diabetes (OR: 2.99, 95% CI [1.22; 7.35]) and existing cardiac diseases (OR: 4.31, 95% CI [1.83; 10.74]) were identified as significant risk factors for the emergence of acute cardiac events. Our findings suggest that COVID-19 vaccination may confer both direct and indirect cardioprotective effects in hospitalized COVID-19 patients.

The online version contains supplementary material available at 10.1007/s10238-024-01367-3.